Media

Published On 13 April

Invitrocue unveils novel cancer detection method, screens first customer in Singapore

Bio-analytic healthcare provider Invitrocue (ASX: IVQ), has advanced its proprietary cancer-detection test by screening its first commercial Onco-PDO customer in Singapore.

Learn more
Published On 30 November

2017 AGM Presentation

2017 AGM Presentation

Learn more
Published On 24 July

Launch of New Joint Innovation Laboratory to Advance Personalised Medicine for Cancer Treatment

L-R: Dr Benjamin Seet, Executive Director of the Biomedical Research Council, A*STAR; His Excellency Bruce Gosper, the Australian High Commissioner to Singapore; Dr Steven Fang, Chief Executive Officer / Founder, Invitrocue Ltd; The Hon Martin Hamilton Smith, Minister for Trade and Investment, South Australian Government; Dr Raj Thampuran, Managing Director, A*STAR; Professor Ng Huck Hui, […]

Learn more
Published On 05 May

A*STAR TV Business Insider – The Story of Invitrocue

Invitrocue is featured in the first episode of A*STAR TV Business Insider. Watch this broadcast as it tells the story of company, the technology and the people.  

Learn more
Published On 22 March

Asia Malaria Images Exhibition

Event: Asia Malaria Images Exhibition Opening Talk (Singapore) Venue: The Pod, Level 16, National Library Board, 100 Victoria Street, Singapore 18806 Date: 09 September 2017, Saturday   Invitrocue is proud to be an official sponsor of the Asia Malaria Image campaign as part of the Company’s corporate social responsibility initiative. Mark this day and visit […]

Learn more
Published On 14 March

Singapore-Australia Cooperation on Science and Technology Takes Off

Singapore-Australia cooperation on science and technology takes off ; Landing Pad start-up accelerator is latest initiative in strategic partnership   The Singapore Government has also boosted co-investment support for promising start-ups specialising in deep-technology, such as medical technology, clean technology and advanced manufacturing and engineering. “Collectively, we expect these initiatives to further boost the local […]

Learn more
Published On 13 March

Second Mention in Speech by Minister Iswaran at the Official Opening of the Australian Landing Pad in Singapore

SPEECH BY MR S ISWARAN, MINISTER FOR TRADE AND INDUSTRY (INDUSTRY), AT THE OFFICIAL OPENING OF THE AUSTRALIAN LANDING PAD IN SINGAPORE, ON MONDAY, 13 MARCH 2017, 1040 HRS, AT BASH (79 AYER RAJAH CRESCENT) International connections are critical to facilitating innovation and supporting Singapore’s startup ecosystem. Excerpt:- 8. One example is home-grown local startup […]

Learn more
Published On 04 March

First Mention in Committee of Supply Debate by Ministry of Trade and Industry

SPEECH BY MR LIM HNG KIANG, MINISTER FOR TRADE AND INDUSTRY (TRADE), DURING THE COMMITTEE OF SUPPLY DEBATE UNDER HEAD V (MINISTRY OF TRADE AND INDUSTRY) ON FRIDAY, 3 MARCH 2017 STAYING OPEN AND CONNECTED Excerpt:- 32.         In addition, Singapore companies can partner larger companies to venture abroad. Invitrocue, a home grown biotechnology firm that was spun-off from A*STAR, […]

Learn more
Published On 10 November

PharmaBoardroom Interview

Biotech CRO InvitroCue Executive director Dr. Steven Fang explains how their technology has disrupted the current clinical trials landscape and the importance of leveraging innovative technologies in meeting future healthcare needs. Interviewer: Could you please introduce to our international readers the main activities of InvitroCue as well as the milestones since its foundation in 2012? […]

Learn more
Published On 25 April

Professor Hanry Yu Presented with A*STAR Scientist-Entrepreneur Award

A*STAR Awards 2016 – Award Ceremony Professor Hanry Yu’s Acceptance Speech “It is with great pleasure that I receive the A*STAR Scientist-Entrepreneur Award. Special thanks to A*STAR for selecting me and an enormous salute to all of this year’s nominees each of whom have made incredible contributions to the scientific and biomedical ecosystem in Singapore. This […]

Learn more
Published On 14 March

InvitroCue – A Singapore-based Startup That Is Transforming Bioanalytics

InvitroCue, a Singapore-based biotech company, made its debut on the Australian Securities Exchange (ASX: IVQ) on Jan 27 2016, – just four years after its founding. The company, a spin-off from A*STAR, announced that it had raised an AUD 3.15 Million (SGD3.17 Million) on the ASX through a reverse takeover. On March 1st, 2016, they […]

Learn more
Published On 05 March

Bioanalytics Start-up InvitroCue is Preparing for the Global Stage

Featured on The Edge Enterprise, The Week of 07 March 2016 Biotech entrepreneur Dr Steven Fang is no stranger to the start-up scene … Fang recently listed bio-analytics firm InvitroCue on the ASX, just four years after the company was founded. “What we’re doing today breaks almost all records. We took four years to build […]

Learn more
Published On 24 February

Insight to InvitroCue’s Success – from Invention to IPO

Insight to InvitroCue’s Success – from Invention to IPO February 23, 2016   On Jan 27 2016, local biotech company InvitroCue made its debut on the Australian Securities Exchange (ASX: IVQ) – just four years after its founding. The company, a spin-off from A*STAR, just announced that it had raised an AUD 3.15 Million (SGD3.17 […]

Learn more
Published On 05 February

Artificial Human Liver Developed for Drug Testing

Featured on Singapore News & Top Stories – The Straits Times 05 Feb 2016 By Lin Yangchen The liver is an important organ in drug testing because all drugs pass through it to be detoxified, a process that reduces or removes harmful substances from the body. By constructing a microscopic 3D scaffold to cultivate liver cells […]

Learn more
Published On 02 February

InvitroCue Takes Tech Licensed From A*STAR To Market

Q How did InvitroCue come about? A (Dr Fang) Many of the technologies that InvitroCue is commercialising today were developed by Professor Yu and his team, who are also working for the company now in its effort to take them to market. The development process took about six to seven years, in collaboration with A*Star, […]

Learn more
Published On 02 February

Regional Liver Cancer Registry To Be Set Up

At Friday’s forum, National Cancer Centre Singapore also signed a separate agreement with local bioanalytics firm InvitroCue. They will be working on a study of 100 patients from at least five countries to try and better understand cancer disease patterns and how they relate to an individual person’s genetic data. Source: http://www.straitstimes.com/singapore/health/regional-liver-cancer-registry-to-be-set-up

Learn more
Published On 30 January

80% Of Liver Cancer Patients Are In Asia

全球肝癌病人 80% 在亚洲地区 (Picture from Left to Right) A/Prof Toh Han Chong Deputy Director NCCS, Prof Pierce Chow Senior Consultant Surgeon NCCS and Dr Steven Fang Executive Director IVQ at the MOU Signing Ceremony held on 29 Jan 2016.   《新明日报》刊。 Source: http://www.nccs.com.sg/Newsroom/MediaReleases/2016MediaReleases/Pages/29Jan2016_1.aspx

Learn more
Published On 28 January

Biotech Firm Shows The Way Onto The Global Stage

28 Jan 2016 The Business Times By Claire Huang SUCCESS stories in the Singapore life sciences sphere are few and far between, but InvitroCue, which targets profitability in seven years, could light the way for other homegrown biotechnology firms seeking to get on the global stage. The biotech firm, a spin-off from the Agency for […]

Learn more